Companion Diagnostics
Companion diagnostics are specialized tests that identify patients most likely to benefit from specific treatments, ensuring personalized and effective therapy. These diagnostics can detect genetic mutations or biomarkers and determine drug susceptibility in pathogens for individual patients. By aligning treatments with individual patient profiles, companion diagnostics enhance the precision, efficacy and cost-effectiveness of medical interventions. Demonstrating the value of companion diagnostics can be challenging as the primary benefit lies in ensuring that expensive therapies are only given to patients most likely to respond, which translates to significant cost savings and improved outcomes over time. Yet, these benefits are not always immediately apparent, making it difficult to justify the initial investment to doctors, insurers, and other stakeholders.
Our solutions can be applied to multiple disease areas. We currently focus on oncology, infection disease and neurology, but we are continuously expanding our portfolio.
Schedule a demo with our experts
Schedule a demo to see how Health Economic Software can improve the market uptake of your products.
